Palouse Capital Management’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-75
Closed -$8.39K 124
2024
Q1
$8.39K Buy
+75
New +$8.09K 0.01% 133
2022
Q2
Sell
-54,641
Closed -$3.1M 85
2022
Q1
$3.1M Buy
54,641
+5,860
+12% +$314K 1.36% 31
2021
Q4
$2.51M Sell
48,781
-6,170
-11% -$303K 1.07% 41
2021
Q3
$2.72M Buy
+54,951
New +$2.98M 1.21% 37
2013
Q4
Sell
-70,885
Closed -$3.7M 119
2013
Q3
$3.7M Sell
70,885
-33,480
-32% -$1.7M 1.49% 27
2013
Q2
$4.93M Buy
+104,365
New +$4.77M 2.09% 14

Other funds holding CAH

Palouse Capital Management's CAH Position: Q2 2024 in Review

Palouse Capital Management sold out of Cardinal Health (CAH) in Q2 2024, closing a stake of 75 shares — an estimated $8.39K sold.

Palouse Capital Management first reported a position in CAH in Q2 2013 and held it in 6 quarters. The position peaked at $4.93M in Q2 2013. 1,011 funds tracked by Wall St. Rank hold CAH as of Q2 2024.

  • Palouse Capital Management reported no remaining Cardinal Health position as of Q2 2024 after selling out during the quarter.
  • Palouse Capital Management sold 75 Cardinal Health shares in Q2 2024, an estimated $8.39K.
  • Palouse Capital Management first reported a position in Cardinal Health in Q2 2013 and held it in 6 quarters.
  • Palouse Capital Management's Cardinal Health position peaked at $4.93M in Q2 2013.
  • 1,011 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2024.

Based on Palouse Capital Management's 13F filing for Q2 2024, filed 12 Aug 2024.